Olive Tree Ventures — 2019 Investments

1 investments dated 2019 · listed companies and verified rows first · show all

Emedgeneemedgene.com in 𝕏Feb 2019 · $6M

Emedgene provides genomic interpretation software that uses explainable AI and automation to prioritize, interpret, curate, and classify genetic variants from sequencing (WGS, WES, panels) and microarray data.

AI & Machine LearningBiotechDigital Health

Co-investorsMindset Venture OTV

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.